A Mechanistic, Multiscale Mathematical Model of Immunogenicity for Therapeutic Proteins: Part 1—Theoretical Model

A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins was formulated by recapitulating key biological mechanisms, including antigen presentation, activation, proliferation, and differentiation of immune cells, secretion of antidrug antibodies (ADA), as well as in vivo disposition of ADA and therapeutic proteins. This system‐level model contains three scales: a subcellular level representing antigen presentation processes by dendritic cells; a cellular level accounting for cell kinetics during humoral immune response; and a whole‐body level accounting for therapeutic protein in vivo disposition. The model simulations for in vivo responses against antigenic protein challenge are consistent with many known immunological observations. By simulating immune responses under various initial parameter conditions, the model suggests hypotheses for future experimental investigation and contributes to the mechanistic understanding of immunogenicity. With future experimental validation, this model may potentially provide a platform to generate and test hypotheses about immunogenicity risk assessment and ultimately aid in immunogenicity prediction.

[1]  D. Rossignol,et al.  Safety, Pharmacokinetics, Pharmacodynamics, and Plasma Lipoprotein Distribution of Eritoran (E5564) during Continuous Intravenous Infusion into Healthy Volunteers , 2004, Antimicrobial Agents and Chemotherapy.

[2]  Gordon Broderick,et al.  Using an agent-based model to analyze the dynamic communication network of the immune response , 2011, Theoretical Biology and Medical Modelling.

[3]  H. Grey,et al.  The minimal number of antigen‐major histocompatibility complex class II complexes required for activation of naive and primed T cells , 1997, European journal of immunology.

[4]  J. Foote,et al.  Kinetic and affinity limits on antibodies produced during immune responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Chirmule,et al.  Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics. , 2010, Clinical immunology.

[6]  A. Khoruts,et al.  Naïve and Memory CD4+ T Cell Survival Controlled by Clonal Abundance , 2006, Science.

[7]  R. Preissner,et al.  Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm , 2011, PloS one.

[8]  G. An,et al.  The Basic Immune Simulator: An agent-based model to study the interactions between innate and adaptive immunity , 2007, Theoretical Biology and Medical Modelling.

[9]  Vibha Jawa,et al.  Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy , 2012, The AAPS Journal.

[10]  Mark S. Sundrud,et al.  Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Mia Y. Platt,et al.  MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length , 2012, Proceedings of the National Academy of Sciences.

[12]  G. I. Bell,et al.  Mathematical Model of Clonal Selection and Antibody Production , 1970, Nature.

[13]  F. Sallusto,et al.  Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells , 2009, The Journal of experimental medicine.

[14]  Massimo Bernaschi,et al.  ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization , 2008, Briefings Bioinform..

[15]  E. Shevach,et al.  Proliferative Assays for T Cell Function , 2004, Current protocols in immunology.

[16]  C. Lubich,et al.  CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice. , 2012, Blood.

[17]  Massimo Bernaschi,et al.  Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System , 2010, PloS one.

[18]  Antonio Lanzavecchia,et al.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells , 1997, Nature.

[19]  Marion Pepper,et al.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.

[20]  C. Janeway,et al.  The Immune System in Health and Disease , 2001 .

[21]  Jessie-F. Fecteau,et al.  Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin‐secreting cells after exposure to low CD154 interaction , 2009, Immunology.

[22]  R Hoh,et al.  Factors influencing T-cell turnover in HIV-1-seropositive patients. , 2000, The Journal of clinical investigation.

[23]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[24]  Qing Zhang,et al.  Immune epitope database analysis resource (IEDB-AR) , 2008, Nucleic Acids Res..

[25]  J. Uhr,et al.  In vitro activation of murine antigen-specific memory B cells by a T-dependent antigen. , 1986, Journal of immunology.

[26]  N. Dillon,et al.  The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress. , 2010, Blood.

[27]  D. Verthelyi,et al.  Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic Proteins , 2010, PloS one.

[28]  Elissa K. Deenick,et al.  Intrinsic Differences in the Proliferation of Naive and Memory Human B Cells as a Mechanism for Enhanced Secondary Immune Responses1 , 2003, The Journal of Immunology.

[29]  Reinhart Heinrich,et al.  The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway , 2003, PLoS biology.

[30]  B. Maillère,et al.  Quantitative analysis of the CD4 T‐cell repertoire specific to therapeutic antibodies in healthy donors , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  M. Foti,et al.  Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. , 1999, International immunology.

[32]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[33]  J. Linderman,et al.  Mathematical modeling of helper T lymphocyte/antigen-presenting cell interactions: analysis of methods for modifying antigen processing and presentation. , 1996, Journal of theoretical biology.

[34]  Massimo Bernaschi,et al.  Computational modeling of the immune response to tumor antigens , 2005 .

[35]  R. Ahmed,et al.  Immunological memory in humans. , 2004, Seminars in immunology.

[36]  Gerald B. Pier,et al.  Immunology, Infection, and Immunity , 2004 .

[37]  Søren Buus,et al.  Functional recombinant MHC class II molecules and high-throughput peptide-binding assays , 2009, Immunome research.

[38]  Massimo Bernaschi,et al.  ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale† , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[39]  D. Kelvin,et al.  In Situ Replication of Immediate Dendritic Cell (DC) Precursors Contributes to Conventional DC Homeostasis in Lymphoid Tissue1 , 2006, The Journal of Immunology.

[40]  B. Kohler.  Mathematically modeling dynamics of T cell responses: predictions concerning the generation of memory cells. , 2007, Journal of theoretical biology.

[41]  Miriam Merad,et al.  Dendritic cell homeostasis. , 2009, Blood.

[42]  Alan S. Perelson,et al.  Agent-based modeling of host–pathogen systems: The successes and challenges , 2008, Information Sciences.

[43]  Morten Nielsen,et al.  Peptide binding predictions for HLA DR, DP and DQ molecules , 2010, BMC Bioinformatics.

[44]  R. Ahmed,et al.  Long-lived plasma cells: a mechanism for maintaining persistent antibody production. , 1998, Current opinion in immunology.

[45]  M. Sykes,et al.  Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. , 2008, Blood.

[46]  K. Iwabuchi,et al.  Low-dose lipopolysaccharide modifies the production of IL-12 by dendritic cells in response to various cytokines. , 2006, Journal of clinical and experimental hematopathology : JCEH.

[47]  H. Dosch,et al.  Limiting dilution analysis of the B cell compartment in human bone marrow , 1986, European journal of immunology.

[48]  F. Sallusto,et al.  Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. , 2000, Science.

[49]  M. Reth,et al.  Oligomeric organization of the B-cell antigen receptor on resting cells , 2010, Nature.

[50]  Klaus Rajewsky,et al.  The half‐lives of serum immunoglobulins in adult mice , 1988, European journal of immunology.

[51]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[52]  K. Rajewsky,et al.  Maintenance of B-cell memory by long-lived cells generated from proliferating precursors , 1990, Nature.

[53]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[54]  M. Nolte,et al.  Inflammatory signals in dendritic cell activation and the induction of adaptive immunity , 2009, Immunological reviews.

[55]  H. Barton,et al.  A Multiscale, Mechanism-Driven, Dynamic Model for the Effects of 5α-Reductase Inhibition on Prostate Maintenance , 2012, PloS one.

[56]  Chi‐Huey Wong,et al.  Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. , 2008, Blood.

[57]  Anne S De Groot,et al.  Immunogenicity of protein therapeutics. , 2007, Trends in immunology.

[58]  A. Scheffold,et al.  Antigen-Reactive T Cell Enrichment for Direct, High-Resolution Analysis of the Human Naive and Memory Th Cell Repertoire , 2013, The Journal of Immunology.

[59]  D. Burshtyn,et al.  Dynamics of peptide binding to purified antibody-bound H-2Db and H-2Db beta 2m complexes. , 1993, Journal of immunology.

[60]  M. Croft,et al.  Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. , 1994, Journal of immunology.

[61]  A. Perelson,et al.  Simulation and Prediction of the Adaptive Immune Response to Influenza A Virus Infection , 2009, Journal of Virology.